Credit Suisse’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.82M | Buy |
60,287
+11,044
| +22% | +$517K | ﹤0.01% | 1636 |
|
|
2023
Q4 | $1.75M | Buy |
49,243
+12,036
| +32% | +$428K | ﹤0.01% | 1968 |
|
|
2023
Q3 | $1.11M | Sell |
37,207
-5,589
| -13% | -$166K | ﹤0.01% | 2230 |
|
|
2023
Q2 | $771K | Buy |
42,796
+11,076
| +35% | +$200K | ﹤0.01% | 2548 |
|
|
2023
Q1 | $509K | Buy |
31,720
+2,038
| +7% | +$32.7K | ﹤0.01% | 2729 |
|
|
2022
Q4 | $543K | Sell |
29,682
-1,384
| -4% | -$25.3K | ﹤0.01% | 2717 |
|
|
2022
Q3 | $611K | Buy |
31,066
+3,630
| +13% | +$71.4K | ﹤0.01% | 2656 |
|
|
2022
Q2 | $511K | Buy |
27,436
+2,506
| +10% | +$46.7K | ﹤0.01% | 2804 |
|
|
2022
Q1 | $547K | Buy |
24,930
+4,613
| +23% | +$101K | ﹤0.01% | 2900 |
|
|
2021
Q4 | $577K | Buy |
20,317
+5,935
| +41% | +$169K | ﹤0.01% | 2926 |
|
|
2021
Q3 | $304K | Buy |
14,382
+92
| +0.6% | +$1.95K | ﹤0.01% | 3250 |
|
|
2021
Q2 | $269K | Buy |
14,290
+3,798
| +36% | +$71.5K | ﹤0.01% | 3321 |
|
|
2021
Q1 | $160K | Sell |
10,492
-7,978
| -43% | -$122K | ﹤0.01% | 3300 |
|
|
2020
Q4 | $261K | Buy |
+18,470
| New | +$261K | ﹤0.01% | 3179 |
|
|
2020
Q3 | – | Sell |
-12,057
| Closed | -$211K | – | 3242 |
|
|
2020
Q2 | $211K | Buy |
+12,057
| New | +$211K | ﹤0.01% | 3073 |
|